Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00098514
Recruitment Status : Completed
First Posted : December 8, 2004
Last Update Posted : December 18, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Geoffrey Shapiro, MD, PhD, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2007
  Actual Study Completion Date : May 2011